CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.648
+0.042 (6.94%)
Mar 9, 2026, 1:15 PM EDT - Market open
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $9.33 million as of March 9, 2026. Its market cap has decreased by -76.55% in one year.
Market Cap
9.33M
Enterprise Value
3.46M
1-Year Change
-76.55%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $9.33M, a decrease of -69.50%. That is a compound annual growth rate of -13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.90M | -56.88% |
| Dec 31, 2025 | 16.00M | -61.17% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 9.68M |
| SeaStar Medical Holding | 9.08M |
| NuCana | 8.99M |
| TransCode Therapeutics | 8.80M |
| Iterum Therapeutics | 8.74M |
| Theriva Biologics | 8.29M |
| Bolt Biotherapeutics | 8.25M |
| PharmaCyte Biotech | 8.08M |